Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Pre-Eclampsia

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Pre-Eclampsia in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Wu, H1
Liu, K1
Zhang, J1
Park, JK1
Jeong, JW1
Kang, MY1
Baek, JC1
Shin, JK1
Lee, SA1
Choi, WS1
Lee, JH1
Paik, WY1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Pre-Eclampsia

ArticleYear
Excess fibronectin 1 participates in pathogenesis of pre-eclampsia by promoting apoptosis and autophagy in vascular endothelial cells.
    Molecular human reproduction, 2021, 05-29, Volume: 27, Issue:6

    Topics: Adult; Apoptosis; Autophagy; Case-Control Studies; Chromones; Endothelial Cells; Female; Fibronectin

2021
Inhibition of the PI3K-Akt pathway suppresses sFlt1 expression in human placental hypoxia models in vitro.
    Placenta, 2010, Volume: 31, Issue:7

    Topics: Cell Line, Tumor; Cell Survival; Chromones; Cobalt; Female; Humans; Hypoxia; Hypoxia-Inducible Facto

2010